Sanofi enters exclusive talks with CD&R over $17bn Opella deal

Sanofi has confirmed its exclusive negotiations with Clayton, Dubilier & Rice (CD&R) for the sale of a 50% stake in its consumer healthcare business, Opella. ... Read More